Areas of Interest
Investigator submissions aimed at expanding clinical and scientific knowledge and improving understanding of our products and therapeutic areas of interest will be considered. Please refer to the current areas of interest below.
TheraSphere
- Use of TheraSphere with personalised dosimetry across BCLC stages to expand access to curative options
- Use in combination with new systemic therapies
- Use of TheraSphere with personalized dosimetry (or expanded dosimetry techniques) in Non‐HCC Liver Disease
- Retrospective comparison with other locoregional therapies
- Use of TheraSphere in liver diseases influenced by geographical differences
- Health economic and quality of life data
- Use of TheraSphere in non-liver disease
Cryoablation
- Use of cryoablation in soft tissue lesions (e.g. breast tumors and early-stage lung cancer)
- Cryoneurolysis for pain (e.g. knee, thoracic, abdominal, neuroma)
- Combination of cryoablation with other therapies (e.g. immunotherapy, radiotherapy and other targeted therapies)
- Use of cryoablation in bone metastases, including in comparison with other treatment modalities
- Use of cryoablation in evolving indications (e.g. thyroid or stellate ganglion targets)
Embolization
- Obsidio use in unique subpopulations & indications (e.g. upper and lower GI and coagulopathic patients)
- Procedural efficiencies and health economic analyses
- Obsidio use in novel indications (e.g. large vessels, venous , lymphatic and type II endoleaks)
- Evaluation of coils in emerging indications & techniques